Biogen (BIIB)

Operating Expenses

$5.46B

TTM · Period ending: · USD

BIIB logo

BIIB Operating Expenses

Latest reported$5.46B
BIIB TTM Operating Expenses ($6.30M → $5.46B)
High-resolution chart · PNG

BIIB operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
511,724,000
490,039,000
472,898,000
525,084,000
575,841,000
634,048,000
683,279,000
638,727,000
584,527,000
531,298,000
483,178,000
473,756,000
433,556,000
401,656,000
383,756,000
349,165,000
346,865,000
302,265,000
248,665,000
218,291,000
161,691,000
153,191,000
151,191,000
131,996,000
129,996,000
129,896,000
138,596,000
138,600,000
139,500,000
139,800,000
130,800,000
191,900,000
179,300,000
149,400,000
121,300,000
29,900,000
13,500,000
15,900,000
18,100,000
19,500,000
19,100,000
16,400,000
14,600,000
9,800,000
6,800,000
11,100,000
15,400,000
20,800,000
24,200,000
23,100,000
20,600,000
16,800,000
15,000,000
10,900,000
8,500,000
7,500,000
6,400,000
6,700,000
6,300,000
8,400,000
11,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.